Health
The Oxford vaccine dilemma – wait for a better jab, or let more people have protection? – Telegraph.co.uk
Regulator seems ready to approve a vaccine with lower efficacy rates. Will it be right giving some people lower chances of being protected?

Drug companies Sanofi and GSK also announced a delay in their Covid-19 vaccine programme on Friday, after trials showed an ‘insufficient response’ in the over-50s.
Some researchers believe the Oxford jab may actually perform better than the 62 per cent efficacy rate suggests. Nobody in the vaccine arm became seriously ill or needed hospital treatment.
Mark Woolhouse, Professor of Infectious Disease Epidemiology at the University of Edinburgh, said: I dont think we should get too hung up on the…
-
Noosa News14 hours ago
Commissioner thanks police officer who threw a speed radar at a car
-
Noosa News21 hours ago
Difficult to diagnose and potentially deadly — this lesser-known disease is becoming more common
-
Noosa News13 hours ago
Defence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News22 hours ago
Countdown on for Noosa Eat & Drink Festival 2025